AETN 最新10-Q变化
将 AETN 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-19 与上一份 10-Q · 2026-05-19
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +16 | −12 | ~2 | 5 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 2 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼、风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-19
On February 17, 2026, Shorepower entered into a merger agreement with Aeternum Health LLC, pursuant to which Aeternum Health merged into Shorepower, with Shorepower as the surviving entity. Upon closing, Shorepower’s CEO and sole director, Jeff Kim, resigned. The Company has divested its existing tr…
As consideration for the merger, the Company is obligated to issue shares to Paul Mann. Aeternum Health will contribute a minimum, $1,500,000 in the form of (a) securing sources of critical minerals and/or contributing know-how and data from a single patient relating to a novel peptide mix in develo…
In connection with the Company’s merger with Aeternum Health LLC and its strategic shift away from its legacy transportation electrification business, the Company disposed of its Shorepower operations during the three months ended June 30, 2026. As a result, the historical operating results of the S…
For the three months ended June 30, 2026 and 2025, the Company recognized losses from the operations of the discontinued business of $13,898 and $105,855, respectively. During the three and six months ended June 30, 2026, the Company also recognized a gain of $2,007,315 and $2,037,315, respectively,…
As a result of the disposition, the operating results of the Shorepower business will not be included in the Company’s continuing operations in future periods. Consequently, the Company’s historical results may not be indicative of its future operating results as it continues to develop and execute …
相对上期删除的文字 · 来源:10-Q · 2026-05-19
On February 17, 2026, the Company entered into a merger agreement with Aeternum Health LLC, pursuant to which Aeternum Health will merge into Shorepower, with Shorepower as the surviving entity. Upon closing, Shorepower’s CEO and sole director, Jeff Kim, will resign and appoint Paul Mann, Aeternum H…
As consideration for the merger, the Company will issue shares representing 51% ownership and 2,000,000 shares of Series B preferred stock (with super voting rights) to Paul Mann. Aeternum Health will contribute assets including intellectual property and data related to a peptide-based longevity tre…
For the three months ended March 31, 2026 compared to the three months ended March 31, 2025
We had total revenue of $2,260 for the three months ended March 31, 2026, compared to $164,657 for the three months ended March 31, 2025, a decrease of $162,397 or 98.6%. We had costs of revenue of $13,461 and $38,383, respectively, and a deduction for revenue share of $776 and $922, respectively, f…
For the three months ended March 31, 2026, the Company incurred professional fees of $9,788 compared to $4,043 for the three months ended March 31, 2025, an increase of $5,745 or 142.1%. Professional fees generally consist of audit, legal, accounting and investor relations fees. In the current perio…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议